For glioma therapy, 2-deoxy-D-glucose-functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) (PEG-PTMC) nanoparticles were used to effectively enhance binding to GLUT1 in a dual targeting strategy involving both BBB transfer and tumor penetration [36]. Here, SLC2A1 is linked to glioma.